Apollon Wealth Management’s TuHURA Biosciences HURA Stock Holding History
Bought
Maintained
Sold
Other funds holding HURA
Apollon Wealth Management's HURA Position: Q3 2026 in Review
Apollon Wealth Management increased its TuHURA Biosciences (HURA) stake by 1% in Q3 2026, buying an estimated $3.41K and bringing the position to 158,089 shares worth $332K. The position accounts for ﹤0.01% of the portfolio, ranked #1242.
Apollon Wealth Management first reported a position in HURA in Q4 2024 and has held it in 8 quarters since. The position peaked at $371K in Q1 2025. 77 funds tracked by Wall St. Rank hold HURA as of Q3 2026.
- Apollon Wealth Management held 158,089 shares of TuHURA Biosciences worth $332K as of Q3 2026.
- Apollon Wealth Management bought 1,570 TuHURA Biosciences shares in Q3 2026, an estimated $3.41K.
- TuHURA Biosciences made up ﹤0.01% of Apollon Wealth Management's portfolio in Q3 2026, its #1242 holding.
- Apollon Wealth Management first reported a position in TuHURA Biosciences in Q4 2024 and has held it in 8 quarters since.
- Apollon Wealth Management's TuHURA Biosciences position peaked at $371K in Q1 2025.
- 77 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q3 2026.
Based on Apollon Wealth Management's 13F filing for Q3 2026, filed 23 Oct 2026.